School of Biomedical Sciences, Department of Biomedical Engineering
The Biomedical Technology and Cell Therapy Research Laboratory is a proud promotor of industrial contributions.
The BTCTRL is proud to be the origin of science and innovation that has been translated into technologies and products that are serving various industries and used by millions of humans globally. The BTCTRL is the place where various technologies were invented and registered with McGill University and finally they have become independent, fully functional companies.
MangoGen develops gene-delivering medical devices to promote wound healing. The novel technology involves a gene-delivering coronary stent including a coating of encapsulated genetically modified baculoviruses to accelerate the healing processes and prevent in-stent restenosis. Connect with MangoGen Pharma!
Nanorapharma USA is a pharmaceutical company that is involved in developing a polymeric nano-delivery vehicle for therapeutics like small interfering RNA (siRNA), pDNA (plasmid DNA), shRNA (short hair-pin RNA), antisense oligonucleotides (ASOs), chemotherapeutic drugs and small molecules. The delivery vehicle developed is a platform technology that can cater its suitability towards different applications such as targeting cancer, neurodegenerative diseases, or for oral delivery of nutraceuticals.
Proviva Pharma is invested in the long term health of citizens globally. They work to understand the role of the microbiome in overall health and develop innovative probiotics for a plethora of disorders including heart health, gastrointestinal diseases, bone, obesity and metabolic disease.
Micropharma is a biopharmaceutical company specializing in cholesterol lowering technologies. The leading product, Cardioviva, is sold across the globe. See Micropharma in the news and connect!
